XML 36 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Aug. 31, 2020
Aug. 31, 2019
Aug. 31, 2018
OPERATING ACTIVITIES      
Loss for the year $ (7,128) $ (16,776) $ (41,024)
Add items not affecting cash:      
Depreciation 177 235 347
Interest expense 5,493 8,355 18,414
Unrealized foreign exchange gain (loss) 128 13 (65)
Share of joint venture expenditures 369 595  
Loss on assets held for sale     2,305
Gain (Loss) on fair value of convertible debt derivatives (3,203) 2,732 (3,726)
(Gain) Loss on marketable securities   (609) 105
Deferred tax expense 72 106  
Stock compensation expense 1,569 787 77
Directors fees paid in deferred share units 142 112  
Net change in non-cash working capital (739) (502) 209
Net cash flows from (used in) operating activities (3,120) (4,952) (23,358)
FINANCING ACTIVITIES      
Share issuance - warrant exercise 48 1,783  
Proceeds from issuance of equity 5,705 25,024 19,882
Equity issuance costs (514) (1,876) (2,562)
Cash received from sale of Maseve     62,000
Costs associated with convertible note     (95)
Convertible note interest paid   (687)  
Cash proceeds from debt   20,000 10,000
Costs associated with debt (40) (228) (866)
Sprott principal repayments   0 (50,000)
Sprott interest paid (2,237) (73) (3,401)
Lease payments made (66)    
Repayment of Liberty debt and production payment termination   (41,023) (23,163)
Cash received from Waterberg partners 1,697 3,522 2,756
Net cash flows from (used in) financing activities 4,593 6,442 14,551
INVESTING ACTIVITIES      
Proceeds from partial sale of interest in Waterberg     16,124
Fees paid on asset held for sale     (1,000)
Transfer to restricted cash (Waterberg)     (5,000)
Expenditures from restricted cash (Waterberg)   126 4,874
Investment in Lion Battery (350) (554)  
Cash received from sale of marketable securities   7,951  
Proceeds from the sale of concentrate     2,016
Performance bonds (67) 19  
Waterberg exploration expenditures (4,953) (6,990) (9,125)
Net cash flows from (used in) investing activities (5,370) 552 7,889
Net decrease in cash and cash equivalents (3,897) 2,042 (918)
Effect of foreign exchange on cash and cash equivalents (345) 491 521
Cash and cash equivalents, beginning of year 5,550 3,017 3,414
Cash and cash equivalents, end of year $ 1,308 $ 5,550 $ 3,017